BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32971279)

  • 41. Treatment of five or more brain metastases with stereotactic radiosurgery.
    Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases.
    Prabhu RS; Turner BE; Asher AL; Marcrom SR; Fiveash JB; Foreman PM; Press RH; Patel KR; Curran WJ; Breen WG; Brown PD; Jethwa KR; Grills IS; Arden JD; Foster LM; Manning MA; Stern JD; Soltys SG; Burri SH
    Neuro Oncol; 2019 Aug; 21(8):1049-1059. PubMed ID: 30828727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Care Patterns for Stereotactic Radiosurgery in Small Cell Lung Cancer Brain Metastases.
    Gjyshi O; Lin SH; Pezzi TA; Ning MS; Ma J; Liu S; Rusthoven CG
    Clin Lung Cancer; 2022 Mar; 23(2):185-190. PubMed ID: 34419375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
    Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whole Brain Radiotherapy Versus Stereotactic Radiosurgery in Poor-Prognosis Patients with One to 10 Brain Metastases: A Randomised Feasibility Study.
    Raman S; Mou B; Hsu F; Valev B; Cheung A; Vallières I; Ma R; McKenzie M; Beaton L; Rackley T; Gondara L; Nichol A
    Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):442-451. PubMed ID: 32085923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Whole brain radiotherapy and stereotactic radiosurgery for patients with recursive partitioning analysis I and lesions <5 cm(3): A matched pair analysis.
    Viani GA; Godoi da Silva LB; Viana BS; Rossi BT; Suguikawa E; Zuliani G
    J Cancer Res Ther; 2016; 12(2):770-4. PubMed ID: 27461649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
    Farris M; McTyre ER; Cramer CK; Hughes R; Randolph DM; Ayala-Peacock DN; Bourland JD; Ruiz J; Watabe K; Laxton AW; Tatter SB; Zhou X; Chan MD
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):131-141. PubMed ID: 28586952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of Large Brain Metastases With Stereotactic Radiosurgery.
    Zimmerman AL; Murphy ES; Suh JH; Vogelbaum MA; Barnett GH; Angelov L; Ahluwalia M; Reddy CA; Chao ST
    Technol Cancer Res Treat; 2016 Feb; 15(1):186-95. PubMed ID: 25633136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment.
    Anderson ES; Postow MA; Wolchok JD; Young RJ; Ballangrud Å; Chan TA; Yamada Y; Beal K
    J Immunother Cancer; 2017 Oct; 5(1):76. PubMed ID: 29037215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.
    Choi CY; Chang SD; Gibbs IC; Adler JR; Harsh GR; Lieberson RE; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):336-42. PubMed ID: 22652105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
    Magnuson WJ; Lester-Coll NH; Wu AJ; Yang TJ; Lockney NA; Gerber NK; Beal K; Amini A; Patil T; Kavanagh BD; Camidge DR; Braunstein SE; Boreta LC; Balasubramanian SK; Ahluwalia MS; Rana NG; Attia A; Gettinger SN; Contessa JN; Yu JB; Chiang VL
    J Clin Oncol; 2017 Apr; 35(10):1070-1077. PubMed ID: 28113019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma.
    Goyal LK; Suh JH; Reddy CA; Barnett GH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1007-12. PubMed ID: 10863072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.
    Patil CG; Pricola K; Sarmiento JM; Garg SK; Bryant A; Black KL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006121. PubMed ID: 28945270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.
    Raleigh DR; Seymour ZA; Tomlin B; Theodosopoulos PV; Berger MS; Aghi MK; Geneser SE; Krishnamurthy D; Fogh SE; Sneed PK; McDermott MW
    J Neurosurg; 2017 Jun; 126(6):1749-1755. PubMed ID: 27367240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy.
    Chen L; Shen C; Redmond KJ; Page BR; Kummerlowe M; Mcnutt T; Bettegowda C; Rigamonti D; Lim M; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):939-947. PubMed ID: 28602418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases.
    Kamath R; Ryken TC; Meeks SL; Pennington EC; Ritchie J; Buatti JM
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1467-72. PubMed ID: 15817352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of single brain metastasis: a practice guideline.
    Mintz A; Perry J; Spithoff K; Chambers A; Laperriere N
    Curr Oncol; 2007 Aug; 14(4):131-43. PubMed ID: 17710205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hospitalization outcomes among brain metastasis patients receiving radiation therapy with or without stereotactic radiosurgery from the 2005-2014 Nationwide Inpatient Sample.
    Beydoun HA; Beydoun MA; Huang S; Eid SM; Zonderman AB
    Sci Rep; 2021 Sep; 11(1):19209. PubMed ID: 34584139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.